Switzerland· 57583001
Nexavar, Filmtabletten
A sorafenib product containing sorafenibum, registered in Switzerland by Bayer (Schweiz) AG and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Sorafenib is registered in 14 of 19 countries.
Countries holding a registration under ATC L01EX02 (sorafenib), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 8 of them publish a price we can compare per daily dose
Sorafenib · ATC L01EX02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of sorafenib costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), so markets compare like for like.
- Switzerland: $125.31 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Sorafenib · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- CH Switzerland$125.31
The record
At a glance
Swissmedic (Switzerland)- Active substance
- sorafenibum
- Manufacturer
- Bayer (Schweiz) AG
- Country
- Switzerland (CH)
- ATC code
- L01EX02
- ATC class
- Sorafenib
- Defined daily dose
- 0.8 g, O
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680575830016112 StkCHF 3112.4
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
598 interactions on record for sorafenib.
Graded by severity as the source publishes them — 85 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sorafenib · interactions on record
598 records
- 85 severe
- 352 moderate
- 11 minor
- 150 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- EdoxabanB01AF03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sorafenib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNEXAVARBayer AG, Leverkusen
- United StatesNexavarBayer HealthCare Pharmaceuticals Inc.
- NetherlandsFENESA 200 mg filmomhulde tablettenZentiva k.s.
- FinlandNexavarAbacus Medicine A/S
- SpainNEXAVAR 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULABayer Ag
- FranceNEXAVAR 200 mg, comprimé pelliculéBAYER AG (ALLEMAGNE)
- PolandNexavarBayer AG
- SwedenNexavar 200 mg Filmdragerad tablettBayer AG
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Sorafenib, Sorafenib Bluefish
- Belgium · Sorafenib Eg, Sorafénib Eg
- Bulgaria · Сорафениб Зентива, Сорафениб Тева
- Cyprus · Rexanib
- Czechia · Sorafenib Pharmagen, Sorafenib Sandoz
- Germany · Sorafeb, Sorafenib Abz
- Denmark · Sorafenib "sandoz", Sorafenib Stada
- Estonia · Sorafenib Sandoz, Sorafenib Teva
- Spain · Sorafenib Dr. Reddys, Sorafenib Eugia
- Finland · Sorafenib Sandoz, Sorafenib Stada
- France · Sorafenib Arrow, Sorafenib Biogaran
- United Kingdom (Northern Ireland) · Sorafenib Sandoz, Sorafenib Teva
- Greece · Revamox, Sorafenib Bioars
- Croatia · Slam 200 Mg Tablete, Sorafenib Alpha-Medical
- Hungary · Fenesa, Renixola
- Iceland · Nexavar, Sorafenib
- Italy · Sorafenib Eg, Sorafenib Medac
- Liechtenstein · Nexavar, Sorafenib Accord
- Lithuania · Sorafenib Sandoz, Sorafenib Teva
- Luxembourg · Sorafenib Eg, Sorafenib Eurogenerics
- Latvia · Sorafenib Lv System, Sorafenib Sandoz
- Malta · Revamox, Sorafenib Pharos
- Netherlands · Fenesa, Sorafeb
- Norway · Nexavar, Sorafenib Accord
- Poland · Sorafenib G.L., Sorafenib Sandoz
- Portugal · Sorafenib, Sorafenib Eugia
- Romania · Sorafenib Dr. Reddy's, Sorafenib Sandoz
- Sweden · Sorafenib Bluefish, Sorafenib Sandoz
- Slovenia · Sorafenib Sandoz, Sorafenib Teva
- Slovakia · Sorafenib, Sorafenib Pharmagen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3a9ae821-97d3-42ce-bb17-da48856b9e6f GET /v1/drugs/3a9ae821-97d3-42ce-bb17-da48856b9e6f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "sorafenibum 200 mg",
"valid_from": "2006-06-01",
"limitations": "[{\"description\":\"Inoperables Leberzellkarzinom; bei Vorliegen einer Leberzirrhose einzig bei erhaltener Leberfunktion (max. Child Pugh A).<br>\\nProgredientes, lokal fortgeschrittenes oder metastasiertes, Radiojod-refraktäres differenziertes Schilddrüsenkarzinom.<br>\\n\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2018-04-01\"}]",
"galenic_form": "Filmtabl 200 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2006-06-01",
"self_retention_pct": 10
}See everything about sorafenib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.